| Literature DB >> 35874996 |
Abstract
Introduction: Previous studies indicated inconsistent associations between daytime napping and cognitive decline. This study aimed to examine the associations between self-reported changes in napping and longitudinal cognitive performance.Entities:
Keywords: afternoon napping; cognitive decline; longitudinal association; old adults; risk
Mesh:
Year: 2022 PMID: 35874996 PMCID: PMC9302202 DOI: 10.3389/fpubh.2022.911498
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Demographic and health characteristics of the study population at baseline.
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| Age, years | 66.70 (5.79) | 66.73 (5.77) | 67.21 (6.05) | 67.23 (6.11) | 66.90 (5.89) | 0.069 |
| BMI, kg/m2 | 22.72 (4.09) | 23.28 (4.20) | 23.27 (3.79) | 23.31 (3.84) | 23.02 (4.01) |
|
| Sleep duration per night, hours | 5.94 (2.07) | 6.11 (1.91) | 5.34 (1.81) | 6.72 (1.94) | 6.16 (1.98) |
|
| Baseline cognition score | 11.80 (6.31) | 13.20 (6.12) | 12.70 (6.56) | 12.70 (6.10) | 12.37 (6.34) |
|
| Gender (male) | 316 (47.2) | 592 (57.4) | 290 (60.3) | 751 (40.8) | 1,949 (48.4) |
|
| High level of education | 36 (5.4) | 70 (6.8) | 26 (5.4) | 73 (4.0) | 205 (5.1) |
|
| Physical activity | ||||||
| Vigorous physical activities | 140 (20.9) | 226 (21.9) | 97 (20.2) | 444 (24.1) | 907 (22.5) | 0.141 |
| Moderate physical activities | 185 (27.6) | 277 (26.8) | 116 (24.1) | 531 (28.8) | 1,109 (27.6) | 0.200 |
| Walking | 316 (47.2) | 460 (44.6) | 183 (38.0) | 855 (46.4) | 1,814 (45.1) |
|
| Depression symptoms | 350 (52.2) | 523 (50.7) | 234 (48.6) | 894 (48.6) | 2,001 (49.7) | 0.349 |
| Taking sleeping pills | 15 (2.2) | 14 (1.4) | 10 (2.1) | 23 (1.2) | 62 (1.5) | 0.228 |
| Current smoking | 341 (50.9) | 559 (54.2) | 282 (58.6) | 1,045 (56.8) | 2,227 (55.3) |
|
| Current alcohol use | 529 (79.0) | 307 (29.7) | 134 (27.9) | 383 (20.8) | 965 (24.0) |
|
| Medical history | ||||||
| Hypertension | 208 (31.0) | 334 (32.4) | 154 (32.0) | 462 (25.1) | 1,158 (28.8) |
|
| Dyslipidemia | 80 (11.9) | 140 (13.6) | 54 (11.2) | 135 (7.3) | 409 (10.2) |
|
| Diabetes | 67 (10.0) | 81 (7.8) | 27 (5.6) | 72 (3.9) | 247 (6.1) |
|
| Cancer | 8 (1.2) | 10 (1.0) | 1 (0.2) | 13 (0.7) | 32 (0.8) | 0.258 |
| Chronic lung diseases | 79 (11.8) | 155 (15.0) | 67 (13.9) | 210 (11.4) | 511 (12.7) |
|
| Liver disease | 25 (3.7) | 40 (3.9) | 19 (4.0) | 72 (3.9) | 156 (3.9) | 0.997 |
| Heart problems | 117 (17.5) | 166 (16.1) | 70 (14.6) | 229 (12.4) | 582 (14.5) |
|
| Stroke | 23 (3.4) | 35 (3.4) | 15 (3.1) | 36 (2.0) | 109 (2.7) | 0.059 |
| Kidney disease | 48 (7.2) | 69 (6.7) | 25 (5.2) | 123 (6.7) | 265 (6.6) | 0.590 |
| Stomach or other digestive disease | 157 (23.4) | 242 (23.4) | 117 (24.3) | 456 (24.8) | 972 (24.2) | 0.836 |
| Emotional, nervous, or psychiatric problems | 15 (2.2) | 13 (1.3) | 9 (1.9) | 22 (1.2) | 59 (1.5) | 0.207 |
| Memory-related disease | 11 (1.6) | 20 (1.9) | 14 (2.9) | 29 (1.6) | 74 (1.8) | 0.265 |
| Arthritis or rheumatism | 271 (40.4) | 382 (37.0) | 182 (37.8) | 759 (41.2) | 1,594 (39.6) | 0.125 |
| Asthma | 29 (4.3) | 54 (5.2) | 31 (6.4) | 86 (4.7) | 200 (5.0) | 0.348 |
BMI, body mass index. The bold values provided in table means that P < 0.05.
Associations between baseline daytime napping and longitudinal cognitive function according to generalized estimating equations (GEE).
|
|
| |
|---|---|---|
|
| ||
| No napping | Ref. | Ref. |
| Short napping | 1.248 (0.773, 1.723) | 0.901 (0.495, 1.344) |
| Moderate napping | 0.772 (0.376, 1.169) | 0.327 (−0.053, 0.707) |
| Long napping | 0.256 (−0.251, 0.763) | −0.032 (−0.519, 0.455) |
|
| ||
| No napping | Ref. | Ref. |
| Napping | 0.810 (0.486, 1.134) | 0.435 (0.125, 0.745) |
| Duration | 0.642 (0.281, 1.004) | 0.218 (−0.130, 0.566) |
| Duration | −1.603 (−3.026, −0.180) | −1.208 (−2.616, 0.201) |
P < 0.001,
P < 0.01,
P < 0.05, β: unstandardized beta Co-efficient, SE: standard error.
Adjusted for age and sex.
Adjusted for age, sex, educational levels, physical activities, BMI, depression, use of tranquilizers, smoking, alcohol consumption, night sleep duration at baseline, medical history including hypertension, dyslipidemia, heart disease, and other 11 chronic diseases.
Associations between baseline daytime napping and longitudinal cognitive function according to generalized estimating equations (GEE).
|
| ||
|---|---|---|
|
|
| |
|
| ||
| No napping | Ref. | Ref. |
| Short napping | 0.251 (0.160, 0.343) | 0.195 (0.107, 0.282) |
| Moderate napping | 0.145 (0.065, 0.225) | 0.077 (−0.001, 0.155) |
| Long napping | 0 (−0.104, 0.105) | −0.043 (−0.146, 0.059) |
|
| ||
| No napping | Ref. | Ref. |
| Napping | 0.147 (0.082, 0.212) | 0.089 (0.025, 0.153) |
| Duration | 0.120 (0.048, 0.193) | 0.055 (−0.017, 0.127) |
| Duration | −0.313 (−0.640, 0.014) | −0.211 (−0.540, 0.118) |
|
| ||
|
| ||
| No napping | Ref. | Ref. |
| Short napping | 0.550 (0.303, 0.796) | 0.385 (0.153, 0.618) |
| Moderate napping | 0.314 (0.105, 0.522) | 0.111 (−0.091, 0.313) |
| Long napping | 0.061 (−0.207, 0.329) | −0.057 (−0.315, 0.201) |
|
| ||
| No napping | Ref. | Ref. |
| Napping | 0.333 (0.163, 0.503) | 0.163 (−0.001, 0.328) |
| Duration | 0.242 (0.052, 0.432) | 0.049 (−0.135, 0.233) |
| Duration | −0.499 (−1.220, 0.222) | −0.245 (−0.980, 0.490) |
|
| ||
|
| ||
| No napping | Ref. | Ref. |
| Short napping | 0.447 (0.249, 0.645) | 0.321 (0.133, 0.510) |
| Moderate napping | 0.314 (0.149, 0.479) | 0.139 (−0.021, 0.300) |
| Long napping | 0.195 (−0.016, 0.405) | 0.069 (−0.138, 0.275) |
|
| ||
| No napping | Ref. | Ref. |
| Napping | 0.330 (0.194, 0.465) | 0.183 (0.051, 0.314) |
| Duration | 0.279 (0.128, 0.431) | 0.114 (−0.034, 0.262) |
| Duration | −0.791 (−1.387, −0.195) | −0.752 (−1.322, −0.182) |
P < 0.001,
P < 0.01,
P < 0.05, β: unstandardized beta Co-efficient, SE: standard error.
Adjusted for age and sex.
Adjusted for age, sex, educational levels, physical activities, BMI, depression, use of tranquilizers, smoking, alcohol consumption, night sleep duration at baseline, medical history including hypertension, dyslipidemia, heart disease, and other 11 chronic diseases.
Associations between changes in daytime napping and global cognition among participants whose napping durations were 30–90 min at baseline.
|
| |||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
|
| |||||
| Model 1 | −1.587 (−2.583, −0.590) | −1.023 (−2.223, 0.177) | Ref. | −1.164 (−2.457, 0.129) | −0.996 (−2.183, 0.191) |
| Model 2 | −1.108 (−2.072, −0.144) | −0.688 (−1.842, 0.466) | Ref. | −0.968 (−2.209, 0.273) | −0.625 (−1.767, 0.517) |
| Model 3 | −0.769 (−1.600, 0.062) | −0.531 (−1.525, 0.463) | Ref. | −0.824 (−1.893, 0.245) | −0.253 (−1.237, 0.732) |
|
| |||||
| Model 1 | −0.824 (−1.767, 0.120) | −0.226 (−1.372, 0.920) | Ref. | 0.070 (−1.118, 1.257) | −0.927 (−2.021, 0.166) |
| Model 2 | −0.445 (−1.364, 0.474) | −0.022 (−1.137, 1.093) | Ref. | 0.301 (−0.849, 1.452) | −0.396 (−1.464, 0.672) |
| Model 3 | −0.128 (−0.911, 0.655) | −0.098 (−1.047, 0.852) | Ref. | 0.364 (−0.616, 1.343) | −0.019 (−0.930, 0.891) |
|
| |||||
| Model 1 | −1.210 (−2.298, −0.121) | 1.328 (−0.040, 2.696) | Ref. | 0.268 (−1.152, 1.688) | −1.952 (−3.183, −0.722) |
| Model 2 | −0.897 (−1.952, 0.158) | 1.198 (−0.114, 2.510) | Ref. | 0.385 (−0.980, 1.751) | −1.558 (−2.738, −0.379) |
| Model 3 | −0.147 (−1.060, 0.766) | 1.002 (−0.129, 2.134) | Ref. | 0.303 (−0.874, 1.480) | −1.123 (−2.141, −0.105) |
Using generalized linear models (GLMs).
P < 0.05,
P < 0.01,
P < 0.001.
Model 1: Adjusted for age and gender.
Model 2: Adjusted for Model 1+ educational levels, physical activities, BMI, depression, use of tranquilizers, smoking, alcohol consumption, night sleep duration at baseline, medical history including hypertension, dyslipidemia, heart disease, and other 11 chronic diseases.
Model 3: Adjusted for Model 2 + baseline global cognition score.
Change in napping presented the variations between napping in wave 2 and napping at baseline, being divided into five groups: decreased >0.5 h/day, decrease 0–0.5 h/day, no change, increased 0–0.5 h/day, and increased >0.5 h/day, the GLMs showed the associations between this change in napping and global cognition scores in wave 2.
Change in napping presented the variations between napping in wave 3 and napping at baseline, being divided into five groups: decreased >0.5 h/day, decrease 0–0.5 h/day, no change, increased 0–0.5 h/day, and increased >0.5 h/day, the GLMs showed the associations between this change in napping and global cognition scores in wave 3.
Change in napping presented the variations between napping in wave 4 and napping at baseline, being divided into five groups: decreased >0.5 h/day, decrease 0–0.5 h/day, no change, increased 0–0.5 h/day, and increased >0.5 h/day, the GLMs showed the associations between this change in napping and global cognition scores in wave 4.
Unstandardized β Co-efficients for adjusted generalized linear models examining the relationships between variations in daytime napping and global cognition at wave 4 among participants whose napping = 0, <30 min or >90 min at baseline.
|
| |||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
|
| |||||
| Model 1 | −0.412 (−1.083, 0.259) | Ref. | −0.787 (−1.722, 0.148) | 0.930 (−0.483, 2.342) | −0.884 (−2.804, 1.035) |
| Model 2 | −0.694 (−1.335, −0.053) | Ref. | −0.764 (−1.654, 0.125) | 0.462 (−0.885, 1.809) | −0.786 (−2.609, 1.038) |
| Model 3 | −0.447 (−1.001, 0.107) | Ref. | −0.537 (−1.305, 0.231) | 0.181 (−0.982, 1.334) | −0.670 (−2.245, 0.904) |
|
| |||||
| Model 1 | −3.712 (−5.977, −1.447) | Ref. | 1.903 (−1.097, 4.902) | −2.568 (−5.282, 0.146) | 0.803 (−2.010, 3.616) |
| Model 2 | −2.593 (−4.763, −0.423) | Ref. | 1.067 (−1.785, 3.919) | −1.990 (−4.588, 0.607) | 0.806 (−1.863, 3.475) |
| Model 3 | −1.391 (−3.245, 0.464) | Ref. | 1.602 (−0.828, 4.033) | −0.795 (−3.013, 1.423) | 1.609 (−0.666, 3.885) |
|
| |||||
| Model 1 | −1.246 (−3.024, 0.533) | Ref. | −0.737 (−2.956, 2.483) | 0.560 (−2.032, 3.151) | 0.135 (−2.879, 3.149) |
| Model 2 | −1.556 (−3.270, 0.158) | Ref. | −0.744 (−2.895, 1.408) | 0.218 (−2.275, 2.710) | −0.195 (−3.091, 2.702) |
| Model 3 | −0.863 (−2.374, 0.647) | Ref. | −0.427 (−2.319, 1.464) | 0.868 (−1.325, 3.061) | 0.480 (−2.068, 3.027) |
.
Model 1: Adjusted for age and gender.
Model 2: Adjusted for Model 1+ educational levels, physical activities, BMI, depression, use of tranquilizers, smoking, alcohol consumption, night sleep duration at baseline, medical history including hypertension, dyslipidemia, heart disease, and other 11 chronic diseases.
Model 3: Adjusted for Model 2 + baseline global cognition score.
Type of napping's variation was decided by patterns of daytime napping in Wave 2–Wave 4.
Excessive, for participants with No napping in Wave 1, they were divided into Excessive group as long as they were in No or Long napping group once from Wave 2 to Wave 4; for participants with Short napping at baseline, they were divided into Excessive group as long as they were in No or Long napping group once from Wave 2 to Wave 4; for participants with Long napping at baseline, they were divided into Excessive group as long as they were in No or Long napping group once from Wave 2 to Wave 4.
No change, for participants with No napping in Wave 1, they were divided into No change group if they maintained in No napping group from Wave 2 to Wave 4; for participants with Short napping at baseline, they were divided into No change group if they maintained in Short napping group once from Wave 2 to Wave 4; for participants with Long napping at baseline, they were divided into No change group if they maintained in Long napping group once from Wave 2 to Wave 4.
Benefit 1, for participants with No napping in Wave 1, they were divided into Benefit 1 group if they maintained No napping in two waves and had an Moderate napping in another wave; for participants with Short napping at baseline, they were divided into Benefit 1 group if they maintained Short napping in two waves and had an Moderate napping in another wave; for participants with Long napping at baseline, they were divided into Benefit 1 group if they maintained an Long napping in two waves and had an Moderate napping in another wave.
Benefit 2, for participants with No napping in Wave 1, they were divided into Benefit 2 group if they maintained in No napping group for one wave and in Moderate napping group for other two waves; for participants with Short napping at baseline, they were divided into Benefit 2 group if they maintained an Short napping in one wave and had two Moderate napping in other two waves; for participants with Long napping at baseline, they were divided into Benefit 2 group if they maintained an Long napping in one wave and had two Moderate napping in other two waves.
Benefit 3, for participants with No napping in Wave 1, they were divided into Benefit 3 group if they maintained in Moderate napping in three waves; for participants with Short napping at baseline, they were divided into Benefit 3 group if they Moderate napping in three waves; for participants with Long napping at baseline, they were divided into Benefit 3 group if they Moderate napping in three waves.